文献速递胃肠外科围术期管理与 ERAS

法国全国数据库:炎症性肠病患者减重手术结局

Outcomes of bariatric surgery in patients with inflammatory bowel disease from a French nationwide database.
PubMed 文献 · Br J Surg · 2023-01-01

IBD组90天死亡率与非IBD组无差异,但非计划再住院率更高(6.0%对3.7%,P=0.004)。术后2年14.6%的IBD患者因IBD相关原因非计划再入院,克罗恩病独立风险高于溃疡性结肠炎(调整OR 1.90,95%CI 1.22-2.97,P=0.005)。

要点

  • IBD患者减重手术后90天死亡率与非IBD患者无差异。
  • IBD患者90天非计划再住院率显著高于非IBD患者(6.0%对3.7%)。
  • 克罗恩病患者术后2年IBD相关非计划再入院风险独立高于溃疡性结肠炎。

核心结论

  • 在严格选择的IBD控制良好患者中,减重手术未增加死亡率或发病率。
  • 克罗恩病患者减重手术后需警惕IBD相关非计划再入院风险。

主要发现

  • IBD组与非IBD组90天死亡率分别为0.049%和0%,无差异。
  • IBD组90天非计划再住院率为6.0%,非IBD组为3.7%(P=0.004)。
  • 术后2年,IBD组86例(14.6%)因IBD管理至少有一次非计划再入院,其中15例住院3天及以上。
  • 多变量分析显示,克罗恩病相比溃疡性结肠炎术后2年IBD相关非计划再入院调整OR为1.90(95%CI 1.22-2.97,P=0.005)。

关键数值与推荐

  • IBD组中55.5%为克罗恩病,44.5%为溃疡性结肠炎。
  • IBD组首选袖状胃切除术(81.1%),其次胃旁路术(14.6%)。
  • IBD组Charlson合并症指数≥1、高血压和糖尿病比例均高于非IBD组(P<0.001)。

临床怎么用

  • 对IBD控制良好的患者,减重手术不增加90天死亡风险,但需关注非计划再住院。
  • 克罗恩病患者减重手术后应加强IBD相关随访,警惕再入院风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The outcomes of bariatric surgery (BS) in patients with chronic inflammatory bowel disease (IBD) remain rarely described. We aimed to evaluate the 90-day morbidity and mortality rates, and the risk of IBD complications 2 years after BS. METHOD: Patients from the French Programme de Médicalisation des Systèmes d'Information (PMSI) database who underwent a primary BS between 2016 and 2018 were included. We identified patients with a previous diagnosis of IBD. Postoperative 90-day (POD90) morbidity and mortality rates were compared between the two groups. The evolution of IBD was followed 2 years after BS. RESULTS: Between 2016 and 2018, 138 980 patients underwent primary BS, including 587 patients with IBD: 326 (55.5 per cent) with Crohn's disease (CD) and 261 (44.5 per cent) with ulcerative colitis (UC). The preferred surgical technique was sleeve gastrectomy, especially in the IBD group (81.1 per cent), followed by gastric bypass (14.6 per cent). Patients with IBD had more comorbidities (Charlson Comorbidity Index of 1 or more, hypertension, and diabetes; P < 0.001) than those without IBD. The POD90 mortality rate did not differ between the two groups (0.049 per cent in the IBD group versus 0 per cent in the non-IBD group), but more unscheduled rehospitalizations at POD90 were observed in patients with IBD (6.0 per cent versus 3.7 per cent; P = 0.004). Two years after BS, 86 patients (14.6 per cent) in the IBD group had at least one unplanned readmission for the management of their IBD; 15 patients stayed for 3 or more days. After multivariable analysis, patients with CD had an independent elevated risk of IBD-related unplanned readmissions 2 years after BS versus UC (adjusted odds ratio 1.90, 95 per cent c.i. 1.22 to 2.97; P = 0.005). CONCLUSION: In a highly selected cohort of patients with well-controlled IBD, BS did not result in added mortality or morbidity. A point of vigilance must be underlined regarding BS in patients with CD.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Corbière L, Scanff A, Desfourneaux V, et al. Outcomes of bariatric surgery in patients with inflammatory bowel disease from a French nationwide database. Br J Surg. 2023. PMID: 36448229. doi:10.1093/bjs/znac398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。